These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36713050)

  • 1. Effect of Triglyceride-Glucose Indices and Circulating PCSK9-Associated Cardiovascular Risk in STEMI Patients with Primary Percutaneous Coronary Artery Disease: A Prospective Cohort Study.
    Zhao X; Song L; Li J; Zhou J; Li N; Yan S; Chen R; Wang Y; Liu C; Zhou P; Sheng Z; Chen Y; Zhao H; Yan H
    J Inflamm Res; 2023; 16():269-282. PubMed ID: 36713050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between TyG index and long-term prognosis of patients with ST-segment elevated myocardial infarction undergoing percutaneous coronary intervention: a retrospective cohort study.
    Zeng D; Wang K; Chen Z; Yao C
    BMJ Open; 2024 Jun; 14(6):e079279. PubMed ID: 38889947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High triglyceride-glucose index is associated with poor prognosis in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention.
    Luo E; Wang D; Yan G; Qiao Y; Liu B; Hou J; Tang C
    Cardiovasc Diabetol; 2019 Nov; 18(1):150. PubMed ID: 31722708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of PCSK9 with inflammation and platelet activation markers and recurrent cardiovascular risks in STEMI patients undergoing primary PCI with or without diabetes.
    Song L; Zhao X; Chen R; Li J; Zhou J; Liu C; Zhou P; Wang Y; Chen Y; Zhao H; Yan H
    Cardiovasc Diabetol; 2022 May; 21(1):80. PubMed ID: 35596184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triglyceride-Glucose Index and New-Onset Atrial Fibrillation in ST-Segment Elevation Myocardial Infarction Patients After Percutaneous Coronary Intervention.
    Ling Y; Fu C; Fan Q; Liu J; Jiang L; Tang S
    Front Cardiovasc Med; 2022; 9():838761. PubMed ID: 35345486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triglyceride glucose index combined with plaque characteristics as a novel biomarker for cardiovascular outcomes after percutaneous coronary intervention in ST-elevated myocardial infarction patients: an intravascular optical coherence tomography study.
    Zhao X; Wang Y; Chen R; Li J; Zhou J; Liu C; Zhou P; Sheng Z; Chen Y; Song L; Zhao H; Yan H
    Cardiovasc Diabetol; 2021 Jun; 20(1):131. PubMed ID: 34183007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triglyceride-glucose body mass index predicts prognosis in patients with ST-elevation myocardial infarction.
    Liu M; Pan J; Meng K; Wang Y; Sun X; Ma L; Yu X
    Sci Rep; 2024 Jan; 14(1):976. PubMed ID: 38200157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proprotein Convertase Subtilisin/Kexin Type 9 and Systemic Inflammatory Biomarker Pentraxin 3 for Risk Stratification Among STEMI Patients Undergoing Primary PCI.
    Zhao X; Song L; Wang Y; Li J; Zhou J; Chen R; Liu C; Zhou P; Sheng Z; Chen Y; Zhao H; Yan H
    J Inflamm Res; 2021; 14():5319-5335. PubMed ID: 34703271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A synergistic effect of the triglyceride-glucose index and the residual SYNTAX score on the prediction of intermediate-term major adverse cardiac events in patients with type 2 diabetes mellitus undergoing percutaneous coronary intervention.
    Xiong S; Chen Q; Zhang Z; Chen Y; Hou J; Cui C; Cheng L; Su H; Long Y; Yang S; Qi L; Chen X; Liu H; Cai L
    Cardiovasc Diabetol; 2022 Jun; 21(1):115. PubMed ID: 35751060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of the triglyceride-glucose index with severity of coronary stenosis and in-hospital mortality in patients with acute ST elevation myocardial infarction after percutaneous coronary intervention: a multicentre retrospective analysis cohort study.
    Lu X; Lin X; Cai Y; Zhang X; Meng H; Chen W; Yu P; Chen X
    BMJ Open; 2024 Mar; 14(3):e081727. PubMed ID: 38521531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjustment of the GRACE score by the triglyceride glucose index improves the prediction of clinical outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Xiong S; Chen Q; Chen X; Hou J; Chen Y; Long Y; Yang S; Qi L; Su H; Huang W; Liu H; Zhang Z; Cai L
    Cardiovasc Diabetol; 2022 Aug; 21(1):145. PubMed ID: 35932019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes mellitus and acute coronary syndrome.
    Ma X; Dong L; Shao Q; Cheng Y; Lv S; Sun Y; Shen H; Wang Z; Zhou Y; Liu X
    Cardiovasc Diabetol; 2020 Mar; 19(1):31. PubMed ID: 32156279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impacts of triglyceride-glucose index on prognosis of patients with type 2 diabetes mellitus and non-ST-segment elevation acute coronary syndrome: results from an observational cohort study in China.
    Zhao Q; Zhang TY; Cheng YJ; Ma Y; Xu YK; Yang JQ; Zhou YJ
    Cardiovasc Diabetol; 2020 Jul; 19(1):108. PubMed ID: 32641127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of Proprotein Convertase Subtilisin/Kexin Type 9 to Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention.
    Choi IJ; Lim S; Lee D; Lee WJ; Lee KY; Kim MJ; Jeon DS
    Am J Cardiol; 2020 Oct; 133():54-60. PubMed ID: 32798044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triglyceride-glucose index is associated with quantitative flow ratio in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention.
    Yu B; Mo Y; Hu X; Wang W; Liu J; Jin J; Lun Z; Luo Bu CR; Dong H; Zhou Y
    Front Cardiovasc Med; 2022; 9():1002030. PubMed ID: 36158820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triglyceride-Glucose Index as a Surrogate Marker of Insulin Resistance for Predicting Cardiovascular Outcomes in Nondiabetic Patients with Non-ST-Segment Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
    Zhao Q; Zhang TY; Cheng YJ; Ma Y; Xu YK; Yang JQ; Zhou YJ
    J Atheroscler Thromb; 2021 Nov; 28(11):1175-1194. PubMed ID: 33191314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of various insulin resistance surrogates on prognostic prediction and stratification following percutaneous coronary intervention in patients with and without type 2 diabetes mellitus.
    Zhao Q; Cheng YJ; Xu YK; Zhao ZW; Liu C; Sun TN; Zhou YJ
    Cardiovasc Diabetol; 2021 Sep; 20(1):190. PubMed ID: 34537077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discordance between the triglyceride glucose index and fasting plasma glucose or HbA1C in patients with acute coronary syndrome undergoing percutaneous coronary intervention predicts cardiovascular events: a cohort study from China.
    Hu C; Zhang J; Liu J; Liu Y; Gao A; Zhu Y; Zhao Y
    Cardiovasc Diabetol; 2020 Jul; 19(1):116. PubMed ID: 32703284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of the triglyceride-glucose index for patients with ischemic heart failure after percutaneous coronary intervention.
    Sun T; Huang X; Zhang B; Ma M; Chen Z; Zhao Z; Zhou Y
    Front Endocrinol (Lausanne); 2023; 14():1100399. PubMed ID: 36814584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of TyG Index and GRACE Risk Score as Long-Term Prognostic Marker in Patients with ACS Complicated with T2DM Undergoing PCI.
    Qin Z; Xu S; Yuan R; Wang Z; Lu Y; Xu Y; Lv Y; Yu F; Bai J; Zhang H; Zhang L; Zhang J; Tang J
    Diabetes Metab Syndr Obes; 2022; 15():3015-3025. PubMed ID: 36196143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.